查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1937888

全球气喘药物市场规模、份额、趋势和成长分析报告（2026-2034）

Global Asthma Therapeutics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计气喘药物市场规模将从 2025 年的 348.4 亿美元成长到 2034 年的 539.1 亿美元，2026 年至 2034 年的复合年增长率为 4.97%。

气喘药物市场正经历显着成长，这主要得益于气喘盛行率的上升以及对有效治疗方法需求的不断增长。随着人们对气喘管理的认识不断提高，医疗服务提供者正致力于制定个人化的治疗方案，以满足每位患者的独特需求。包括生物製药和标靶治疗在内的气喘药物创新正在改变气喘管理的格局，为重度气喘和难治性气喘患者带来新的希望。此外，智慧吸入器和数位健康解决方案的开发也为提高用药依从性和监测效果提供了有力支持。

此外，对预防性护理和早期疗育的日益重视正在影响气喘药物市场。随着医疗保健系统优先考虑积极主动的管理策略，对有效气喘药物的需求正在飙升。同时，对病患教育和自我管理的日益重视，使病患能够更好地控制气喘，从而改善治疗效果并降低医疗成本。

此外，远端医疗和远距监测技术的兴起正在促进气喘管理的改善。患者现在无需亲自就诊即可获得医疗专业人员的咨询和后续观察，从而更轻鬆地控制症状。在新冠肺炎疫情的背景下，这一趋势尤其重要，因为远端医疗已成为必不可少的手段。总之，气喘药物市场有望实现强劲成长，其特点是创新、注重个人化医疗以及致力于改善气喘患者的生活品质。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球气喘药物市场（依药物类别划分）

  • 市场分析、洞察与预测
  • 联合治疗（吸入性糖皮质激素/长效β2受体激动剂）
  • 长效β2受体激动剂（LABA）
  • 短效β2受体激动剂（SABA）
  • 吸入性皮质类固醇（ICS）
  • 口服和静脉注射皮质类固醇
  • 白三烯调节剂
  • 其他的

5. 全球气喘药物市场（依治疗类型划分）

  • 市场分析、洞察与预测
  • 长期气喘控制药物
  • 快速起效（急救）药物

6. 全球气喘药物市场依给药途径划分

  • 市场分析、洞察与预测
  • 局部的
  • 口服
  • 注射

7. 全球气喘药物市场（依分销管道划分）

  • 市场分析、洞察与预测
  • 实体店面
  • 医院药房
  • 电子商务

8. 全球气喘药物市场依最终用途划分

  • 市场分析、洞察与预测
  • 医院和诊所
  • 门诊手术中心
  • 居家医疗环境

9. 全球气喘药物市场（依地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第十一章 公司简介

  • 主要公司的市占率分析
  • 公司简介
    • AstraZeneca
    • Boehringer Ingelheim
    • Cipla Ltd
    • Covis Pharma
    • GSK Plc
    • Merck & Co. Inc
    • Novartis Pharmaceuticals Corporation
    • Regeneron Pharmaceuticals Inc
    • Sanofi
    • Teva Pharmaceutical Industries Ltd
简介目录
Product Code: VMR11217451

The Asthma Therapeutics Market size is expected to reach USD 53.91 Billion in 2034 from USD 34.84 Billion (2025) growing at a CAGR of 4.97% during 2026-2034.

The asthma therapeutics market is experiencing substantial growth, driven by the increasing prevalence of asthma and the rising demand for effective treatment options. As awareness of asthma management improves, healthcare providers are focusing on personalized treatment plans that address the unique needs of each patient. Innovations in asthma therapeutics, including biologics and targeted therapies, are transforming the landscape of asthma management, offering new hope for patients with severe and uncontrolled asthma. These advancements are complemented by the development of smart inhalers and digital health solutions that enhance medication adherence and monitoring.

Moreover, the growing emphasis on preventive care and early intervention is influencing the asthma therapeutics market. As healthcare systems prioritize proactive management strategies, the demand for effective asthma medications is surging. Additionally, the increasing focus on patient education and self-management is empowering individuals to take control of their asthma, leading to improved outcomes and reduced healthcare costs.

Furthermore, the rise of telemedicine and remote monitoring technologies is facilitating better asthma management. Patients can now access healthcare professionals for consultations and follow-ups without the need for in-person visits, making it easier to manage their condition. This trend is particularly relevant in the context of the COVID-19 pandemic, where remote care has become essential. In conclusion, the asthma therapeutics market is set for robust growth, characterized by innovation, a focus on personalized care, and a commitment to improving the quality of life for asthma patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Class

  • Combination Therapies (ICS/LABAs)
  • Long-Acting Beta Agonists (LABAs)
  • Short-Acting Beta Agonists (SABAs)
  • Inhaled Corticosteroids (ICS)
  • Oral And Intravenous Corticosteroids
  • Leukotriene Modifiers
  • Other

By Treatment Type

  • Long-Term Asthma Control Medications
  • Quick-Relief (Rescue) Medications

By Route Of Administration

  • Topical
  • Oral
  • Injectables

By Distribution Channel

  • Brick & Mortar
  • Hospital Pharmacies
  • E-Commerce

By End-Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

COMPANIES PROFILED

  • AstraZeneca, Boehringer Ingelheim, Cipla Ltd, Covis Pharma, GSK plc, Merck Co Inc, Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals Inc, Sanofi, Teva Pharmaceutical Industries Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ASTHMA THERAPEUTICS MARKET: BY DRUG CLASS 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Drug Class
  • 4.2. Combination Therapies (ICS/LABAs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Long-Acting Beta Agonists (LABAs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Short-Acting Beta Agonists (SABAs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Inhaled Corticosteroids (ICS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Oral And Intravenous Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Leukotriene Modifiers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ASTHMA THERAPEUTICS MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment Type
  • 5.2. Long-Term Asthma Control Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Quick-Relief (Rescue) Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ASTHMA THERAPEUTICS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Route Of Administration
  • 6.2. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Injectables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ASTHMA THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution Channel
  • 7.2. Brick & Mortar Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ASTHMA THERAPEUTICS MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL ASTHMA THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Drug Class
    • 9.2.2 By Treatment Type
    • 9.2.3 By Route Of Administration
    • 9.2.4 By Distribution Channel
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Drug Class
    • 9.3.2 By Treatment Type
    • 9.3.3 By Route Of Administration
    • 9.3.4 By Distribution Channel
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Drug Class
    • 9.4.2 By Treatment Type
    • 9.4.3 By Route Of Administration
    • 9.4.4 By Distribution Channel
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Drug Class
    • 9.5.2 By Treatment Type
    • 9.5.3 By Route Of Administration
    • 9.5.4 By Distribution Channel
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Drug Class
    • 9.6.2 By Treatment Type
    • 9.6.3 By Route Of Administration
    • 9.6.4 By Distribution Channel
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ASTHMA THERAPEUTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 AstraZeneca
    • 11.2.2 Boehringer Ingelheim
    • 11.2.3 Cipla Ltd
    • 11.2.4 Covis Pharma
    • 11.2.5 GSK Plc
    • 11.2.6 Merck & Co. Inc
    • 11.2.7 Novartis Pharmaceuticals Corporation
    • 11.2.8 Regeneron Pharmaceuticals Inc
    • 11.2.9 Sanofi
    • 11.2.10 Teva Pharmaceutical Industries Ltd